Business Development Partnerships

We are actively seeking strategic partners that align with our vision.


We are actively seeking research and licensing partners to fully leverage the transformational potential of our KINect® platform for drug discovery. Specific areas of interest include:

  • Kinases inhibitors for autoimmune diseases, such as rheumatoid arthritis, chronic inflammation disease (e.g. inflammatory bowel disease), autoinflammatory diseases (e.g. CAPS, Stills Disease), and cancer. 
  • New therapeutic applications for our cysteinome-targeted chemical library representing 60% of the kinome.

Learn more about the KINect® platform

If you are interested in participating in an investigator-initiated study, find out more.